News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,778 Results
Type
Article (88028)
Company Profile (825)
Press Release (781905)
Multimedia
Podcasts (198)
Webinars (28)
Section
Business (233295)
Career Advice (4147)
Deals (39885)
Drug Delivery (151)
Drug Development (91434)
Employer Resources (205)
FDA (18400)
Job Trends (17430)
News (397976)
Policy (39974)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3014)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (149)
Alliances (56982)
ALS (181)
Alzheimer's disease (1798)
Antibody-drug conjugate (ADC) (351)
Approvals (18584)
Artificial intelligence (634)
Autoimmune disease (166)
Automation (39)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (490)
Bladder cancer (164)
Brain cancer (65)
Breast cancer (671)
Cancer (5092)
Cardiovascular disease (451)
Career advice (3572)
Career pathing (41)
CAR-T (307)
CDC (59)
Celiac Disease (2)
Cell therapy (839)
Cervical cancer (38)
Clinical research (77095)
Collaboration (1843)
Company closure (5)
Compensation (1176)
Complete response letters (73)
COVID-19 (2994)
CRISPR (99)
C-suite (882)
Cystic fibrosis (155)
Data (6337)
Decentralized trials (2)
Denatured (73)
Depression (152)
Diabetes (537)
Diagnostics (7243)
Digital health (48)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (304)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (241)
Earnings (100234)
Editorial (65)
Employer branding (25)
Employer resources (173)
Events (135213)
Executive appointments (1034)
FDA (21619)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1569)
Gene editing (218)
Generative AI (67)
Gene therapy (678)
GLP-1 (1140)
Government (5450)
Grass and pollen (8)
Guidances (387)
Healthcare (20953)
HIV (63)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (297)
Immuno-oncology (62)
Indications (104)
Infectious disease (3284)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (121)
Intellectual property (252)
Interviews (816)
IPO (17963)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (70)
Kidney cancer (17)
Labor market (94)
Layoffs (660)
Leadership (40)
Legal (10161)
Liver cancer (99)
Longevity (16)
Lung cancer (683)
Lymphoma (382)
Machine learning (45)
Management (66)
Manufacturing (865)
MASH (175)
Medical device (15045)
Medtech (15101)
Mergers & acquisitions (23000)
Metabolic disorders (1417)
Multiple sclerosis (165)
NASH (23)
Neurodegenerative disease (358)
Neuropsychiatric disorders (102)
Neuroscience (3135)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5112)
Now hiring (66)
Obesity (689)
Opinion (336)
Ovarian cancer (169)
Pain (216)
Pancreatic cancer (234)
Parkinson's disease (303)
Partnered (39)
Patents (513)
Patient recruitment (493)
Peanut (60)
People (66952)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23823)
Phase 2 (33454)
Phase 3 (25204)
Pipeline (5239)
Policy (340)
Postmarket research (3554)
Preclinical (10695)
Press Release (72)
Prostate cancer (251)
Psychedelics (56)
Radiopharmaceuticals (303)
Rare diseases (927)
Real estate (7441)
Recruiting (80)
Regulatory (29089)
Reports (67)
Research institute (2729)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (261)
Series B (198)
Service/supplier (30)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4334)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (123)
Vaccines (1151)
Venture capital (98)
Weight loss (475)
Women's health (92)
Worklife (22)
Date
Today (92)
Last 7 days (651)
Last 30 days (2578)
Last 365 days (32913)
2026 (3089)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (344)
Arkansas (14)
Asia (51589)
Australia (9062)
California (11656)
Canada (3345)
China (1182)
Colorado (495)
Connecticut (505)
Delaware (351)
Europe (118537)
Florida (1712)
Georgia (375)
Hawaii (4)
Idaho (68)
Illinois (972)
India (70)
Indiana (547)
Iowa (24)
Japan (435)
Kansas (133)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1464)
Massachusetts (8567)
Michigan (363)
Minnesota (668)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (127)
New Hampshire (86)
New Jersey (3128)
New Mexico (33)
New York (3077)
North Carolina (1621)
North Dakota (10)
Northern California (5589)
Ohio (357)
Oklahoma (23)
Oregon (55)
Pennsylvania (2325)
Puerto Rico (23)
Rhode Island (50)
South America (1664)
South Carolina (67)
South Dakota (1)
Southern California (4501)
Tennessee (177)
Texas (1836)
United States (42015)
Utah (351)
Vermont (1)
Virginia (292)
Washington D.C. (88)
Washington State (984)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
There are 870,778 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IPO
Eikon Clocks Largest IPO Since 2024, Generate, AgomAb Follow
Analysts are cautiously optimistic about an IPO rebound for biopharma.
BioSpace
is keeping track of companies that seek to trade on the public markets this year.
February 6, 2026
·
5 min read
·
Tristan Manalac
Immunology and inflammation
Priovant Plots Path to Phase 3 as Brepocitinib Clears Mid-Stage Skin Disease Study
According to Priovant, the Phase 2 BEACON study is the first industry-sponsored placebo-controlled trial in cutaneous sarcoidosis to deliver positive data.
February 6, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Charles River, Thermo Fisher Lay Off Staff Amid Site Closures
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
February 6, 2026
·
51 min read
·
BioSpace Editorial Staff
GLP-1
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
Novo Nordisk has also spoken out strongly against Hims & Hers’ compounded Wegovy pill, with CEO Maziar Mike Doustdar telling investors the knockoff version is a waste of money.
February 6, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Invitation to the Presentation of Cantargia’s Annual Results for 2025
February 6, 2026
·
1 min read
Press Releases
Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (sac-TMT) Approved by NMPA in HR+/HER2- Breast Cancer
February 6, 2026
·
6 min read
Press Releases
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting
February 6, 2026
·
3 min read
Press Releases
HUTCHMED to Announce 2025 Final Results
February 6, 2026
·
1 min read
Press Releases
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
February 6, 2026
·
2 min read
Press Releases
Coloplast A/S - Interim Financial Report, Q1 2025/26
February 6, 2026
·
6 min read
1 of 87,078
Next
